Assessment of cyclooxygenase-2 expression in canine hemangiosarcoma, histiocytic sarcoma, and mast cell tumor

Veterinary Pathology

Volumn 42, Issue 3, 2005, Pages 350-353

  Heller, D A ^b   Clifford, C A ^b   Goldschmidt, M H ^b   Holt, D E ^b   Manfredi, M J ^b   Sorenmo, K U ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

Cancer; Cyclooxygenase 2; Dogs; Prostaglandins

Indexed keywords

CYCLOOXYGENASE 2; ENDOPEROXIDE; IMMUNOGLOBULIN G;

ANGIOSARCOMA; ARTICLE; CHEMOTHERAPY; DOG; IMMUNOHISTOCHEMISTRY; INTERPERSONAL COMMUNICATION; KIDNEY TUBULE EXCRETION; LABORATORY; MACULA DENSA; MASTOCYTOMA; NONHUMAN; PATHOLOGY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SARCOMA; STAINING; SURVIVAL; TUMOR CLASSIFICATION;

ANIMALS; CYCLOOXYGENASE 2; DOG DISEASES; DOGS; HEMANGIOSARCOMA; HISTIOCYTIC DISORDERS, MALIGNANT; IMMUNOHISTOCHEMISTRY; MAST-CELL SARCOMA; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

CANIS FAMILIARIS;

EID: 19044377445     PISSN: 03009858     EISSN: None     Source Type: Journal    
DOI: 10.1354/vp.42-3-350     Document Type: Article

References (29)

1. Clifford CA, Mackin AJ, Henry CJ: Treatment of canine hemangiosarcoma: 2000 and beyond. J Vet Intern Med 14(5):479-485, 2000
2. Costa C, Soares R, Reis-Filho JS, Leitao D, Amendoeira I, Schmitt FC: Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. J Clin Pathol 55(6):429-434, 2002
3. Dempke W, Rie C, Grothey A, Schmoll HJ: Cyclooxygenase-2: a novel target for cancer chemotherapy? J Cancer Res Clin Oncol 127(7):411-417, 2001
4. Dickens DS, Kozielski R, Khan J: Cyclooxygenase-2 expression in pediatric sarcomas. Pediatr Dev Pathol 5(4):356-364, 2002
5. Dore M, Lanthier I, Sirois J: Cyclooxygenase-2 expression in canine mammary tumors. Vet Pathol 40(2):207-212, 2003
6. Edwards JG, Faux SP, Plummer SM, Abrams KR, Walker RA, Waller DA, O'Byrne KJ: Cyclooxygenase-2 expression is a novel prognostic factor in malignant mesothelioma. Clin Cancer Res 8(6):1857-1862, 2002
7. Fosslien E: Molecular pathology of cyclooxygenase-2 in neoplasia. Ann Clin Lab Sci 30(1):3-21, 2000
8. Fosslien E: Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis. Ann Clin Lab Sci 31(4):325-348, 2001
9. Giles FJ, Kantarjian HM, Bekele BN, Cortes JE, Faderl S, Thomas DA, Manshouri T, Rogers A, Keating MJ, Talpaz M, O'Brien S, Albitar M: Bone marrow cyclooxygenase-2 levels are elevated in chronic-phase chronic myeloid leukaemia and are associated with reduced survival. Br J Haematol 119(1):38-45, 2002
10. Hammer AS, Couto CG, Filppi J, Getzy D, Shank K: Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin, and cyclophosphamide) in dogs with hemangiosarcoma. J Vet Intern Med 5(3):160-166, 1991
11. Hinz B, Brune K: Cyclooxygenase-2-10 years later. J Pharmacol Exp Ther 300(2):367-375, 2002
12. Khan KN, Stanfield KM, Trajkovic D, Knapp DW: Expression of cyclooxygenase-2 in canine renal cell carcinoma. Vet Pathol 38(1):116-119, 2001
13. Kim YB, Kim GE, Cho NH, Pyo HR, Shim SJ, Chang SK, Park HC, Suh CO, Park TK, Kim BS: Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy. Cancer 95(3):531-539, 2002
14. Knapp DW, Richardson RC, Chan TC, Bottoms GD, Widmer WR, DeNicola DB, Teclaw R, Bonney PL, Kuczek T: Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med 8(4):273-278, 1994
15. Konturek PC, Konturek SJ, Pierzchalski P: Gastric MALT-lymphoma, gastrin and cyclooxygenases. Acta Gastroenterol Belg 65(1):17-23, 2002
16. McEntee MF, Cates JM, Neilsen N: Cyclooxygenase-2 expression in spontaneous intestinal neoplasia of domestic dogs. Vet Pathol 39(4):428-436, 2002
17. Mohammed SI, Knapp DW, Bostwick DG, Foster RS, Khan KN, Masferrer JL, Woerner BM, Snyder PW, Koki AT: Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder. Cancer Res 15;59(22):5647-5650, 1999
18. Pestili de Almeida EM, Piche C, Sirois J, Dore M: Expression of cyclo-oxygenase-2 in naturally occurring squamous cell carcinomas in dogs. J Histochem Cytochem 49(7):867-875, 2001
19. Prymak C, McKee LJ, Goldschmidt MH, Glickman LT: Epidemiologic, clinical, pathologic, and prognostic characteristics of splenic hemangiosarcoma and splenic hematoma in dogs: 217 cases (1985). J Am Vet Med Assoc 193(6):706-712, 1988
20. Reddy ST, Wadleigh DJ, Herschman HR: Transcriptional regulation of the cyclooxygenase-2 gene in activated mast cells. J Biol Chem 275(5):3107-3113, 2000
21. Schmidt BR, Glickman NW, DeNicola DB, de Gortari AE, Knapp DW: Evaluation of piroxicam for the treatment of oral squamous cell carcinoma in dogs. J Am Vet Med Assoc 1;218(11):1783-1786, 2001
22. Seguin B, Leibman NF, Bregazzi VS, Ogilvie GK, Powers BE, Dernell WS, Fettman MJ, Withrow SJ: Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996-1999). J Am Vet Med Assoc 218(7):1120-1123, 2001
23. Stack E, DuBois RN: Role of cyclooxygenase inhibitors for the prevention of colorectal cancer. Gastroenterol Clin North Am 30(4):1001-1010, 2001
24. Taketo MM: Cyclooxygenase-2 inhibitors in tumorigenesis (part I). J Natl Cancer Inst 90(20):1529-1536, 1998
25. Tamura M, Sebastian S, Gurates B: Vascular endothelial growth factor up-regulates cyclooxygenase-2 expression in human endothelial cells. J Clin Endocrinol Metab 87(7):3504-3507, 2001
26. Thun MJ, Henley SJ, Patrono C: Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 20; 94(4):252-266, 2002
27. Vail DM: Histiocytic disorders. In: Small Animal Clin-ical Oncology, ed. Withrow SJ, and MacEwen EG, 3rd ed., pp. 667-671. WB Saunders, Philadelphia, PA, 2001
28. Wikstrom K, Ohd JF, Sjolander A: Regulation of leukotriene-dependent induction of cyclooxygenase-2 and Bcl-2. Biochem Biophys Res Commun 302(2):330-335, 2003
29. Yu HG, Huang JA, Yang YN: The effects of acetylsalicylic acid on proliferation, apoptosis, and invasion of cyclooxygenase-2 negative colon cancer cells. Eur J Clin Invest 32(11):838-846, 2002